Search - tctmd.com

Displaying 21 - 36 of 36

Sort: Relevancy | Date

News Daily News

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

Yael L. Maxwell

October 05, 2016

News Industry News

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

July 22, 2015

News Daily News

CTOs Relatively Frequent in Patients Without Previously Known CAD

Nicole Lou

June 30, 2015

News Daily News

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Caitlin E. Cox

May 08, 2015

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Daily News

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

September 27, 2013

News Daily News

Stress CMR for CAD Matches Prognostic Utility of More Established Techniques

L.A. McKeown

June 03, 2013

News Daily News

SCAI: Interventionalists Deserve Pay for Emergent STEMI Call

Caitlin E. Cox

April 26, 2013

News Daily News

Revascularization Can Reverse Some Myocardial Damage, CMR Imaging Suggests

L.A. McKeown

March 09, 2013

News Conference News TCT 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

October 26, 2012

News Daily News

Pilot Study Suggests Safety of Cell Therapy for Ischemic Stroke

Caitlin E. Cox

July 09, 2012

News Daily News

Registry Characterizes Prevalence, Management of CTOs Found on Diagnostic Cath

March 05, 2012

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Daily News

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

L.A. McKeown

October 28, 2011

News Daily News

CUPID: Gene Therapy Holds Promise in Heart Failure

July 12, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

Advertisement

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

CTOs Relatively Frequent in Patients Without Previously Known CAD

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

Stress CMR for CAD Matches Prognostic Utility of More Established Techniques

SCAI: Interventionalists Deserve Pay for Emergent STEMI Call

Revascularization Can Reverse Some Myocardial Damage, CMR Imaging Suggests

Future Looks Bright for Stem Cell-Based Myocardial Therapy

Pilot Study Suggests Safety of Cell Therapy for Ischemic Stroke

Registry Characterizes Prevalence, Management of CTOs Found on Diagnostic Cath

No LateTIME Benefit for Cell Therapy After Primary PCI

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

CUPID: Gene Therapy Holds Promise in Heart Failure

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content